Mišura Jakobac, K.; Milunović, V.; Kušec, V.; Hrabač, P.; Martinović, M.; Radić-Krišto, D.; Ostojić Kolonić, S.; Pavliša, G.
Biomarkers Affecting Treatment Outcomes of Febrile Neutropenia in Hematological Patients with Lymphomas: Is Presepsin the New Promising Diagnostic and Prognostic Biomarker? J. Clin. Med. 2025, 14, 2238.
https://doi.org/10.3390/jcm14072238
AMA Style
Mišura Jakobac K, Milunović V, Kušec V, Hrabač P, Martinović M, Radić-Krišto D, Ostojić Kolonić S, Pavliša G.
Biomarkers Affecting Treatment Outcomes of Febrile Neutropenia in Hematological Patients with Lymphomas: Is Presepsin the New Promising Diagnostic and Prognostic Biomarker? Journal of Clinical Medicine. 2025; 14(7):2238.
https://doi.org/10.3390/jcm14072238
Chicago/Turabian Style
Mišura Jakobac, Karla, Vibor Milunović, Vesna Kušec, Pero Hrabač, Marko Martinović, Delfa Radić-Krišto, Slobodanka Ostojić Kolonić, and Gordana Pavliša.
2025. "Biomarkers Affecting Treatment Outcomes of Febrile Neutropenia in Hematological Patients with Lymphomas: Is Presepsin the New Promising Diagnostic and Prognostic Biomarker?" Journal of Clinical Medicine 14, no. 7: 2238.
https://doi.org/10.3390/jcm14072238
APA Style
Mišura Jakobac, K., Milunović, V., Kušec, V., Hrabač, P., Martinović, M., Radić-Krišto, D., Ostojić Kolonić, S., & Pavliša, G.
(2025). Biomarkers Affecting Treatment Outcomes of Febrile Neutropenia in Hematological Patients with Lymphomas: Is Presepsin the New Promising Diagnostic and Prognostic Biomarker? Journal of Clinical Medicine, 14(7), 2238.
https://doi.org/10.3390/jcm14072238
